Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:10 AM
Ignite Modification Date:
2025-12-25 @ 12:10 AM
NCT ID:
NCT06868758
Eligibility Criteria:
Inclusion Criteria:
* Female breast cancer patients aged ≥18 years planned for neoadjuvant therapy.
* Histopathologically confirmed HER2-positive status (IHC 3+ or IHC 2+ with positive FISH confirmation).
* Mentally competent, no psychiatric disorders, with good compliance to treatment and follow-up.
* Voluntarily participate and provide written informed consent.
Exclusion Criteria:
* HER2-negative breast cancer.
* Pregnant, planning pregnancy, or lactating women.
* History of allergic predisposition or known/suspected allergy to study drugs.
* Participation in other clinical trials within the past 4 weeks or planned enrollment.
* Other conditions deemed ineligible by the investigator.
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT06868758
Study Brief:
Protocol Section:
NCT06868758